DrugPatentWatch Database Preview

Details for Patent: 10,413,543

« Back to Dashboard

Which drugs does patent 10,413,543 protect, and when does it expire?

Patent 10,413,543 protects EZALLOR and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 10,413,543

Title:	Stable multiparticulate pharmaceutical composition of rosuvastatin
Abstract:	A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
Inventor(s):	Dharmadikari; Nitin Bhalachandra (Mumbai, IN), Zala; Yashoraj (Mumbai, IN), Gadkari; Ashwini (Mumbai, IN)
Assignee:	SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (Mumbai, IN)
Application Number:	15/042,479
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 10,413,543

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sun Pharma Global	EZALLOR	rosuvastatin calcium	CAPSULE;ORAL	208647-001	Dec 18, 2018		RX	Yes	No			Y
Sun Pharma Global	EZALLOR	rosuvastatin calcium	CAPSULE;ORAL	208647-002	Dec 18, 2018		RX	Yes	No			Y
Sun Pharma Global	EZALLOR	rosuvastatin calcium	CAPSULE;ORAL	208647-003	Dec 18, 2018		RX	Yes	No			Y
Sun Pharma Global	EZALLOR	rosuvastatin calcium	CAPSULE;ORAL	208647-004	Dec 18, 2018		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 10,413,543

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
India	3351/MUM/2015	Sep 1, 2015

International Family Members for US Patent 10,413,543

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3344242
World Intellectual Property Organization (WIPO)	2017037740